But France’s biggest drugmaker is not in hurry to do M&A
PARIS: France’s biggest drugmaker, Sanofi, which missed out on a major takeover deal last month, said it expected 2017 earnings per share to be stable or slightly lower.
Already a subscriber? Log in.
Limited time offer:
Just RM5 per month.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!